172 related articles for article (PubMed ID: 31172516)
1. Understanding the structural basis of species selective, stereospecific inhibition for Cryptosporidium and human thymidylate synthase.
Czyzyk DJ; Valhondo M; Jorgensen WL; Anderson KS
FEBS Lett; 2019 Aug; 593(15):2069-2078. PubMed ID: 31172516
[TBL] [Abstract][Full Text] [Related]
2. Structure activity relationship towards design of cryptosporidium specific thymidylate synthase inhibitors.
Czyzyk DJ; Valhondo M; Deiana L; Tirado-Rives J; Jorgensen WL; Anderson KS
Eur J Med Chem; 2019 Dec; 183():111673. PubMed ID: 31536894
[TBL] [Abstract][Full Text] [Related]
3. Two crystal structures of dihydrofolate reductase-thymidylate synthase from Cryptosporidium hominis reveal protein-ligand interactions including a structural basis for observed antifolate resistance.
Anderson AC
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Mar; 61(Pt 3):258-62. PubMed ID: 16511011
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the crossover helix impairs dihydrofolate reductase activity in the bifunctional enzyme TS-DHFR from Cryptosporidium hominis.
Vargo MA; Martucci WE; Anderson KS
Biochem J; 2009 Feb; 417(3):757-64. PubMed ID: 18851711
[TBL] [Abstract][Full Text] [Related]
5. Structural studies provide clues for analog design of specific inhibitors of Cryptosporidium hominis thymidylate synthase-dihydrofolate reductase.
Kumar VP; Cisneros JA; Frey KM; Castellanos-Gonzalez A; Wang Y; Gangjee A; White AC; Jorgensen WL; Anderson KS
Bioorg Med Chem Lett; 2014 Sep; 24(17):4158-61. PubMed ID: 25127103
[TBL] [Abstract][Full Text] [Related]
6. Nonconserved residues Ala287 and Ser290 of the Cryptosporidium hominis thymidylate synthase domain facilitate its rapid rate of catalysis.
Doan LT; Martucci WE; Vargo MA; Atreya CE; Anderson KS
Biochemistry; 2007 Jul; 46(28):8379-91. PubMed ID: 17580969
[TBL] [Abstract][Full Text] [Related]
7. Targeting the TS dimer interface in bifunctional Cryptosporidium hominis TS-DHFR from parasitic protozoa: Virtual screening identifies novel TS allosteric inhibitors.
Ruiz VG; Czyzyk DJ; Kumar VP; Jorgensen WL; Anderson KS
Bioorg Med Chem Lett; 2020 Aug; 30(16):127292. PubMed ID: 32631514
[TBL] [Abstract][Full Text] [Related]
8. Explaining an unusually fast parasitic enzyme: folate tail-binding residues dictate substrate positioning and catalysis in Cryptosporidium hominis thymidylate synthase.
Martucci WE; Vargo MA; Anderson KS
Biochemistry; 2008 Aug; 47(34):8902-11. PubMed ID: 18672899
[TBL] [Abstract][Full Text] [Related]
9. Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states.
Chen D; Jansson A; Sim D; Larsson A; Nordlund P
J Biol Chem; 2017 Aug; 292(32):13449-13458. PubMed ID: 28634233
[TBL] [Abstract][Full Text] [Related]
10. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
Senkovich O; Schormann N; Chattopadhyay D
Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
[TBL] [Abstract][Full Text] [Related]
11. Substituted pyrrolo[2,3-d]pyrimidines as Cryptosporidium hominis thymidylate synthase inhibitors.
Kumar VP; Frey KM; Wang Y; Jain HK; Gangjee A; Anderson KS
Bioorg Med Chem Lett; 2013 Oct; 23(19):5426-8. PubMed ID: 23927969
[TBL] [Abstract][Full Text] [Related]
12. Novel non-active site inhibitor of Cryptosporidium hominis TS-DHFR identified by a virtual screen.
Martucci WE; Udier-Blagovic M; Atreya C; Babatunde O; Vargo MA; Jorgensen WL; Anderson KS
Bioorg Med Chem Lett; 2009 Jan; 19(2):418-23. PubMed ID: 19059777
[TBL] [Abstract][Full Text] [Related]
13. Understanding the molecular mechanism of substrate channeling and domain communication in protozoal bifunctional TS-DHFR.
Anderson KS
Protein Eng Des Sel; 2017 Mar; 30(3):253-261. PubMed ID: 28338744
[TBL] [Abstract][Full Text] [Related]
14. Novel allosteric covalent inhibitors of bifunctional Cryptosporidium hominis TS-DHFR from parasitic protozoa identified by virtual screening.
Ruiz V; Czyzyk DJ; Valhondo M; Jorgensen WL; Anderson KS
Bioorg Med Chem Lett; 2019 Jun; 29(11):1413-1418. PubMed ID: 30929953
[TBL] [Abstract][Full Text] [Related]
15. Binding of the anticancer drug ZD1694 to E. coli thymidylate synthase: assessing specificity and affinity.
Rutenber EE; Stroud RM
Structure; 1996 Nov; 4(11):1317-24. PubMed ID: 8939755
[TBL] [Abstract][Full Text] [Related]
16. Kinetic characterization of bifunctional thymidylate synthase-dihydrofolate reductase (TS-DHFR) from Cryptosporidium hominis: a paradigm shift for ts activity and channeling behavior.
Atreya CE; Anderson KS
J Biol Chem; 2004 Apr; 279(18):18314-22. PubMed ID: 14966126
[TBL] [Abstract][Full Text] [Related]
17. Human thymidylate synthase is in the closed conformation when complexed with dUMP and raltitrexed, an antifolate drug.
Phan J; Koli S; Minor W; Dunlap RB; Berger SH; Lebioda L
Biochemistry; 2001 Feb; 40(7):1897-902. PubMed ID: 11329255
[TBL] [Abstract][Full Text] [Related]
18. The crystal structure of thymidylate synthase from Pneumocystis carinii reveals a fungal insert important for drug design.
Anderson AC; Perry KM; Freymann DM; Stroud RM
J Mol Biol; 2000 Mar; 297(3):645-57. PubMed ID: 10731418
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.
Jones TR; Varney MD; Webber SE; Lewis KK; Marzoni GP; Palmer CL; Kathardekar V; Welsh KM; Webber S; Matthews DA; Appelt K; Smith WW; Janson CA; Villafranca JE; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Moomaw EW; Bartlett CA; Morse CA
J Med Chem; 1996 Feb; 39(4):904-17. PubMed ID: 8632414
[TBL] [Abstract][Full Text] [Related]
20. The crystal structure of dihydrofolate reductase-thymidylate synthase from Cryptosporidium hominis reveals a novel architecture for the bifunctional enzyme.
O'Neil RH; Lilien RH; Donald BR; Stroud RM; Anderson AC
J Eukaryot Microbiol; 2003; 50 Suppl():555-6. PubMed ID: 14736160
[No Abstract] [Full Text] [Related]
[Next] [New Search]
